Sign in
OGEN Stock Price, Chart, Stats & News
Oragenics, Inc.
Save
Oragenics, Inc. (OGEN) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
OGEN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 1.37% |
ROA | -97.76% |
ROE | -244.19% |
D/E | 27.45x |
Interest coverage ratio | -11.91x |
OGEN valuation
P/E | – |
P/S | – |
P/B | 0.27x |
P/CF | -0.24x |
P/FCF | -0.25x |
P/OCF | -0.24x |
PEG | 0.70x |
EV multiple | 35.87x |
About
Oragenics, Inc. (OGEN) is a U. S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option.
Similar securities
Based on sector and market capitalization
Report issue